About 1,330,000 results
Open links in new tab
  1. 363720 (AVII) Stock Price, News, Quote & History - Yahoo Finance

    Find the latest 363720 (AVII) stock quote, history, news and other vital information to help you with your stock trading and investing.

  2. AVII: AVI Biopharma, Inc. Latest Stock Price, Analysis, News and ...

    Get real-time AVI Biopharma, Inc. (AVII) stock price, news, financials, community insights, and trading ideas. Join 10 million+ investors and traders tracking markets in real-time on Stocktwits.

  3. Avi Biopharma Stock Quote AVII - Stock Price, News, Charts, …

    Avi Biopharma (AVII) stock price, charts, trades & the US's most popular discussion forums. Free forex prices, toplists, indices and lots more.

  4. (AVII): Stock Price, Quote and News - BNN Bloomberg

    Real-time stock price, in-depth analysis, and the latest news for (AVII).

  5. Avi Biopharma ( AVII ) Stock Price Quote - TradingCharts

    Stock price quotation for Avi Biopharma, symbol AVII, Nasdaq Stock Exchange. This quote is updated continuously during trading hours.

  6. AVII Stock Quote - AVII Stock Price Today

    AVII stock quote, chart and news. Get AVII's stock price today.

  7. 363720 (AVII) Stock Price, News, Quote & History - Yahoo Finance

    Find the latest 363720 (AVII) stock quote, history, news and other vital information to help you with your stock trading and investing.

  8. Stock Quote - AVI-BioPharma-Inc Summary - Quicken

    Get AVII stock quote information for AVI-BioPharma-Inc, including a stock overview, one-click scorecard, industry position, and the latest headlines.

  9. AVI Biopharma, Inc. (AVII) Fundamental & Financial Data

    Get all financial information for AVI Biopharma, Inc. (AVII) including Market Capitalization, PE Ratio, EBITDA, EPS, previous close and open price, 52 week high & 52 week low, Beta and …

  10. Avii Stock Price, Funding, Valuation, Revenue & Financial …

    See Avii funding rounds, investors, investments, exits and more. Evaluate their financials based on Avii's post-money valuation and revenue.